{
  "id": "cluster_4_doc3",
  "content": "Quarterly provider network analysis shows 23% increase in rheumatology visits within Silverpine network. 68% of biologic therapy approvals under Policy RX-45B were processed within 7 days. Three providers accounted for 82% of infusion center referrals.",
  "metadata": {
    "format": "insurance_memo"
  }
}